Qiao, K., Gong, L., Tian, Y., Wang, H
Other oral medications may come with their own set of side effects
However, several drugs, including teprotumumab and BIIB-022, which target IGF-1R, have not shown good therapeutic effects in clinical trials, possibly due to the lack of reliable IGF-1R inhibition biomarkers
It holds the potential to increase overall energy levels, boosting a persons daily performance
While antiobesity peptides from food show promise for weight management, ensuring their safety and obtaining regulatory approval are crucial
The potential side effects are manageable when monitored by a healthcare provider who regularly monitors your blood work and adjusts your treatment as needed